Results 61 to 70 of about 4,950 (174)

Combined determination of highly sensitive troponin T and copeptin for early exclusion of acute myocardial infarction: first experience in an emergency department of a general hospital

, 2011
Ulrich Lotze1, Holger Lemm2, Anke Heyer2, Karin Müller31Department of Internal Medicine, German Red Cross Hospital Sondershausen, Sondershausen, 2Department of Internal Medicine, 3Department of Laboratory Medicine, Saale-Unstrut Hospital Naumburg ...
Mueller, null Mueller, null Lemm, null Heyer, Ulrich Lotze, Lemm, Lotze U, Heyer   +7 more
core   +1 more source

Copeptin: a biochemical predictor of metabolic syndrome in children and adolescents with obesity

Egyptian Pediatric Association Gazette
Background Copeptin hormone is a stable arginine vasopressin biomarker. High concentrations of this peptide have been linked to obesity and metabolic syndrome.
Marwa Farouk Mira, Ghada Mohammad Anwar, Ghada Maher Thabet, Randa Ebrahim Nofal, Samah Ahmed Hassanein   +4 more
doaj   +1 more source

Concentrations of the stress hormone copeptin increase upon hypoglycaemia in patients with type 1 diabetes dependent of hypoglycaemia awareness.

PLoS ONE, 2013
ObjectiveCopeptin, a marker for stress mirroring vasopressin concentrations, has been shown to increase upon insulin-induced hypoglycaemia in patients after transsphenoidal surgery of pituitary adenomas.
Eleonora Seelig, Stefan Bilz, Ulrich Keller, Fabian Meienberg, Mirjam Christ-Crain   +4 more
doaj   +1 more source

Transient Postoperative Diabetes Insipidus With Hypovolemic Shock Temporally Associated With Dexmedetomidine, Propofol, and Sevoflurane: A Case Report

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Dexmedetomidine, propofol, and sevoflurane are widely used anesthetic agents, but reports of water metabolism disturbances—particularly drug‐induced diabetes insipidus (DI)—associated with their use remain extremely rare. We report a case of a 51‐year‐old Chinese man who developed abrupt high‐volume polyuria (> 600 mL/h; 24‐h output of 8750 mL)
Yuan Meng, Xiaoxiao Qu, Yue Jin, Chengwei Yin, Geping Zhang, Fang Xie, Rong Shi   +6 more
wiley   +1 more source

Copeptin as a predictive marker of incident heart failure

ESC Heart Failure, 2021
Aims Heart failure (HF) is a common disease with increasing prevalence and poor prognosis. The vasopressin (VP) marker copeptin predicts development of diabetes mellitus, diabetic heart disease, coronary artery disease, and premature mortality.
Fredrika Schill, Simon Timpka, Peter M. Nilsson, Olle Melander, Sofia Enhörning   +4 more
doaj   +1 more source

Predictive value of copeptin as a severity marker of community-acquired pneumonia

Electronic Physician, 2017
Background: Pneumonia is the leading cause of death in children. Few studies have explored the predictive value of copeptin in pediatric pneumonia.
Gamal Baheeg Mohamed, Madeha Abdellah Saed, Abdelhakeem Abdelmohsen Abdelhakeem, Kalid Salah, Abdelrahman Mamdouh Saed   +4 more
doaj   +1 more source

Copeptin: a potential blood biomarker for acute ischemic stroke

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2021
Background Copeptin is a new blood biomarker for acute ischemic stroke which emerged to assist clinicians with decision-making. Serum copeptin can accurately reflect vasopressin concentration, which plays a role in aggravation of inflammatory responses ...
Mohammed I. Oraby, Rasha H. Soliman, Rehab M. Abd Elkareem, Amna I. Mohammed   +3 more
doaj   +1 more source

Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival

Critical Care, 2017
Background Acute-on-chronic liver failure (ACLF) is characterized by the presence of acute decompensation (AD) of cirrhosis, organ failure, and high short-term mortality rates.
Annarein J. C. Kerbert, Hein W. Verspaget, Àlex Amorós Navarro, Rajiv Jalan, Elsa Solà, Daniel Benten, François Durand, Pere Ginès, Johan J. van der Reijden, Bart van Hoek, Minneke J. Coenraad, for the CANONIC Study Investigators of the EASL-CLIF Consortium   +11 more
doaj   +1 more source

Copeptin in cardiovascular disease and dysglycemia

, 2021
Background: The impaired prognosis in patients with cardiovascular disease (CVD) and dysglycemia is not fully explained by traditional risk markers, among them hyperglycemia and hyperlipidemia.
Maria Smáradóttir (18665269)
core  

The role of copeptin in kidney disease.

, 2022
20.500.12530/87849Copeptin is a 39-amino acid glycopeptide that is secreted equimolecularly with arginine-vasopressin (AVP) from the prepro-hormone AVP in the posterior pituitary.
Fernández-Reyes, María José, Díez, Juan J, Iglesias, Pedro, Silvestre, Ramona A   +3 more
core   +1 more source